Seizures in Patients with Chronic Hepatitis C Treated with NS3/4A Protease Inhibitors: Does Pharmacological Interaction Play a Role?

Pharmacology ◽  
2013 ◽  
Vol 92 (5-6) ◽  
pp. 235-237 ◽  
Author(s):  
Laura Milazzo ◽  
Felicia Stefania Falvella ◽  
Carlo Magni ◽  
Cristina Gervasoni ◽  
Anna Maria Peri ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Protease Inhibitors ◽  
Chronic Hepatitis C ◽  
Pharmacological Interaction

scholarly journals Low SVR Rates in Clinical Practice for Treating Genotype 1 Chronic Hepatitis C with Protease Inhibitors Boceprevir and Telaprevir

2014 ◽  
Vol 60 (1) ◽  
pp. 272-274 ◽  
Author(s):  
Perry H. Dubin ◽  
Seth N. Sclair ◽  
Rene Rico ◽  
Amelia K. Boehme ◽  
Emerson Y. Chen ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Clinical Practice ◽  
Hepatitis C ◽  
Protease Inhibitors ◽  
Chronic Hepatitis C ◽  
Genotype 1

scholarly journals Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population

2016 ◽  
Vol 4 ◽  
pp. 133-137
Author(s):  
Anna Piekarska ◽  
Ewa Koślińska-Berkan ◽  
Kamila Wójcik ◽  
Anna Skubała ◽  
Maciej Jabłkowski ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Protease Inhibitors ◽  
Chronic Hepatitis C ◽  
First Generation ◽  
Real Life ◽  
Direct Costs ◽  
Hepatitis C Treatment

scholarly journals Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis C

2016 ◽  
Vol 50 ◽  
pp. 1-5 ◽  
Author(s):  
Elif Sargin Altunok ◽  
Murat Sayan ◽  
Sila Akhan ◽  
Bilgehan Aygen ◽  
Orhan Yildiz ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Protease Inhibitors ◽  
Chronic Hepatitis C ◽  
Resistance Mutations ◽  
Drug Resistance Mutations ◽  
Turkish Patients
Sign in / Sign up

Export Citation Format

Share Document